References
- Groves F, Travis L, Devesa S, . Waldenstrom's macroglobulinemia: incidence patterns in the United States, 1988-1994. Cancer 1998;82:1078–1081.
- Surveillance, Epidemiology, and End Results (SEER) Program, SEER*Stat Database: Incidence – SEER 9 Regs Research Data, Nov 2010 Sub (1973-2008) < Katrina/Rita Population Adjustment > – linked to county attributes – total U.S., 1969–2009 counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2011, based on the November 2010 submission. Available from: www.seer.cancer.gov
- Morel P, Duhamel A, Gobbi P, . International prognostic scoring system for Waldenstrom macroglobulinemia. Blood 2009; 113:4163–4170.
- Dhodapkar M, Duhamel A, Gobbi P, . Long-term survival in Waldenstrom macroglobulinemia: 10-year follow-up of Southwest Oncology Group-directed intergroup trial S9003. Blood 2009; 113:793–796.
- Kristinsson SY. Patterns of survival in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: a population-based study of 1,555 patients diagnosed in Sweden from 1980 to 2005. Clin Lymphoma Myeloma Leuk 2011;11:68–73.
- Kastritis E, Kyrtsonis M, Hatjiharissi E, . No significant improvement in the outcome of patients with Waldenstrom's macroglobulinemia treated over the last 25 years. Am J Hematol 2011;86:479–483.
- Brenner H, Gondos A, Pulte D. Recent major improvement in long-term survival of younger patients with multiple myeloma. Blood 2008;111:2521–2526.
- Kumar S, Rajkumar S, Dispenzieri A, . Improved survival in multiple myeloma and the impact of novel therapies. Blood 2008;111:2516–2520.
- Owen R. Developing diagnostic criteria in Waldenstrom's macroglobulinemia. Semin Oncol 2003;30:196–200.
- Herrinton L, Weiss N. Incidence of Waldenstrom's macro- globulinemia. Blood 1993;82:3148–3150.